NCT05868863

Brief Summary

Bone pathologies such as fragility fractures and neoplastic bone lesions are frequently encountered in rheumatology. When these lesions affect the pelvis, they are responsible both for pain that is sometimes very disabling, but also for significant functional disorders due to their location. Different methods may be used to treat these lesions. The current challenge is to use less and less invasive techniques such as radio-guided cementoplasty to be able to treat all types of people, especially the most fragile. Among the elderly, the prevalence of these bone pathologies continues to increase due to the aging of the population and the improvement of diagnostic means.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
13mo left

Started Nov 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress86%
Nov 2019Jun 2027

Study Start

First participant enrolled

November 1, 2019

Completed
3.5 years until next milestone

First Submitted

Initial submission to the registry

April 18, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 22, 2023

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

September 20, 2024

Status Verified

September 1, 2024

Enrollment Period

7.6 years

First QC Date

April 18, 2023

Last Update Submit

September 19, 2024

Conditions

Keywords

Cementoplastybone pelvicelderly

Outcome Measures

Primary Outcomes (1)

  • Feasibility of the technique

    Collect from medical records the number of procedures that were completed and performed as theoretically intended.

    Months: 3

Secondary Outcomes (4)

  • Safety of the technique by number of adverse events

    Months: 3

  • Number of Analgesic intake before and after the procedure

    Months: 3

  • Analysis Functional criteria: walking

    Months: 3

  • Analysis Functional criteria: early rising

    Months: 3

Study Arms (1)

osteoporotic fractures or neoplastic lesions of the bony pelvis

Patient aged 80 and over suffering from osteoporotic fractures or neoplastic lesions of the bony pelvis treated by percutaneous cementoplasty with or without screw fixation at university hospital center of Saint-Etienne between January 1st 2012 and February 28th 2023 will be included. Analysis datas of medical record.

Other: datas of medical record.

Interventions

Analysis datas of medical record: * Feasibility of the technique * Safety of the technique with evaluation by Cardiovascular and Interventional Radiological Society of Europe (CIRSE) scale * Analgesic intake before and after the procedure * Functional criteria: early rising, walking

osteoporotic fractures or neoplastic lesions of the bony pelvis

Eligibility Criteria

Age80 Years+
Sexall
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with lesion of the bony pelvis treated by percutaneous cementoplasty with or without screw fixation at university hospital center of Saint-Etienne between January 1st 2012 and February 28th 2023 will be included.

You may qualify if:

  • Patients with lesion of the bony pelvis treated by percutaneous cementoplasty with or without screw fixation at university hospital center of Saint-Etienne between January 1st 2012 and February 28th 2023

You may not qualify if:

  • Other interventional treatment at the same time and at the same location

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Saint-Etienne

Saint-Etienne, France

RECRUITING

Study Officials

  • Sylvain GRANGE, MD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sylvain GRANGE, MD

CONTACT

Hella TCHEIR, resident

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 18, 2023

First Posted

May 22, 2023

Study Start

November 1, 2019

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 1, 2027

Last Updated

September 20, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations